Bibliografía

9/08/2016

image_pdfimage_print

1. OMS. WHO | Ebola outbreak 2014-2015. WHO.

2. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola Virus Disease in West Africa — Clinical Manifestations and Management. N Engl J Med. 2014;371(22):2054-2057. doi:10.1056/NEJMp1413084.

3. CDC. 2014 Ebola Outbreak in West Africa | Ebola Hemorrhagic Fever | CDC. http:// www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/index.html.

4. MSSSI. Informe Resumen Sobre Las Actuaciones Realizadas En España En Relación a La Epidemia de EVE. Marzo 2014 – Enero 2016.; 2016. http://www.msssi.gob.es/profesionales/saludPublica/ccayes/alertasActual/ebola/docs/Informe_actuaciones_Espana_14.01.2016.pdf. Accessed September 19, 2016.

5. Lopaz MA, Amela C, Ordobas M, et al. First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014. Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull. 2015;20(1). http://www.ncbi.nlm.nih.gov/pubmed/25613651. Accessed September 19, 2016.

6. WHO. WHO consultation on Ebola vaccines. WHO. www.who.int/immunization/diseases/ebola/WHO_consultation_ebola_sep2014/en/. Published 2014. Accessed September 19, 2016.

7. Kanapathipillai R, Henao Restrepo AM, Fast P, et al. Ebola Vaccine — An Urgent International Priority. N Engl J Med. 2014;371(24):2249-2251. doi:10.1056/NE- JMp1412166.

8. WHO. Ebola vaccines, therapies, and diagnostics. Questions and Answers. WHO. www.who.int/medicines/emp_ebola_q_as/en/. Published 2015. Accessed September 19, 2016.

9. Henao-Restrepo AM, Longini IM, Egger M, et al. Effi cacy and eff ectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386(29):857-866. doi:10.1016/S0140-6736(15)61117-5.

10. Agnandji ST, Huttner A, Zinser ME, et al. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. N Engl J Med. 2016;374(17):1647-1660. doi:10.1056/NEJ- Moa1502924.

11. SAGE Experts Group on EVD Vaccine and Vaccination. Ebola Vaccines and Vaccination Report of the SAGE Working Group on Ebola Vaccines and Vaccination with Provisional Recommendations for Vaccination.; 2015. http://www.who.int/immunization/sage/meetings/2015/october/2_WHO_SAGE_WG_ebola_vaccines_and_immunization_MPP_VM_AMHR.pdf. Accessed September 19, 2016.

12. Henao-Restrepo, Ana Maria et al.Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)The Lancet , Volume 389 , Issue 10068 , 505 – 518

image_pdfimage_print

Subir al menú